Profile of the Alere i Influenza A & B assay: a pioneering molecular point-of-care test

Expert Review of Molecular Diagnostics

Volumn 18, Issue 5, 2018, Pages 403-409

  Wang, Hongmei ^a,b   Deng, Jikui ^a   Tang, Yi Wei ^b,c  

^a SHENZHEN CHILDREN'S HOSPITAL   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Influenza viruses A and B; isothermal nucleic acid amplification technology; nasal swabs; nasopharyngeal swabs; nicking enzyme amplification reaction; rapid molecular diagnosis

Indexed keywords

ARTICLE; HUMAN; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; LIMIT OF DETECTION; NASOPHARYNX; NONHUMAN; NOSE SMEAR; POINT OF CARE TESTING; SENSITIVITY AND SPECIFICITY; VIRUS STRAIN; GENETICS; INFLUENZA; INFLUENZAVIRUS B; MOLECULAR DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; REPRODUCIBILITY; VIROLOGY;

HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INFLUENZAVIRUS B; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE TESTING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 85047273218     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1080/14737159.2018.1466703     Document Type: Article

References (47)

1. Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2017;14(17):33292–33293.
2. Uyeki TM, Katz JM, Jernigan DB., Novel influenza A viruses and pandemic threats. Lancet. 2017;389(10085):2172–2174.
3. Doll MK, Winters N, Boikos C, et al. Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses. J Antimicrob Chemother. 2017;72(11):2990–3007.
4. Beigel JH, Bao Y, Beeler J, et al. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Lancet Infect Dis. 2017;17(12):1255–1265.
5. Marty FM, Vidal-Puigserver J, Clark C, et al. Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. Lancet Respir Med. 2017;5(2):135–146.
6. Carman WF, Wallace LA, Walker J, et al. Rapid virological surveillance of community influenza infection in general practice. Bmj. 2000;321(7263):736–737.
7. Merckx J, Wali R, Schiller I, et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a Systematic review and meta-analysis. Ann Intern Med. 2017;167(6):394–409.
8. Huang HS, Tsai CL, Chang J, et al. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2017;2(17):30643–30649.
9. Huang S, Abe K, Bennett S, et al. Disposable autonomous device for swab-to-result diagnosis of influenza. Anal Chem. 2017;89(11):5776–5783.
10. Paules C, Subbarao K., Influenza. Lancet. 2017;390(10095):697–708.
11. O’Leary MF, Chappell JD, Stratton CW, et al. Complex febrile seizures followed by complete recovery in an infant with high-titer 2009 pandemic influenza A (H1N1) virus infection. J Clin Microbiol. 2010;48(10):3803–3805.
12. Poehling KA, Zhu Y, Tang YW, et al. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med. 2006;160(7):713–718.
13. Bell J, Bonner A, Cohen DM, et al. Multicenter clinical evaluation of the novel Alere i Influenza A&B isothermal nucleic acid amplification test. J Clin Virol. 2014;61(1):81–86.
14. Sikkema RS, Freidl GS, de Bruin E, et al. Weighing serological evidence of human exposure to animal influenza viruses - a literature review. Euro Surveill. 2016;21:44.
15. Peaper DR, Landry ML. Rapid diagnosis of influenza: state of the art. Clin Lab Med. 2014;34(2):365–385.
16. Tang YW, Gonsalves S, Sun JY, et al. Clinical evaluation of the luminex NxTAG respiratory pathogen panel. J Clin Microbiol. 2016;54(7):1912–1914. Epub 02016 Apr 00427.
17. Deng J, Ma Z, Huang W, et al. Respiratory virus multiplex RT-PCR assay sensitivities and influence factors in hospitalized children with lower respiratory tract infections. Virol Sin. 2013;28(2):97–102.
18. Tang YW, Lowery KS, Valsamakis A, et al. Clinical accuracy of a PLEX-ID flu device for simultaneous detection and identification of influenza viruses A and B. J Clin Microbiol. 2013;51(1):40–45.
19. Stramer SL, Collins C, Nugent T, et al. Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors. J Infect Dis. 2012;205(6):886–894.
20. Loens K, Goossens H, de Laat C, et al. Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season. J Clin Microbiol. 2006;44(1):166–171.
21. Yu Y, Chen Z, Jian W, et al. Ultrasensitive electrochemical detection of avian influenza A (H7N9) virus DNA based on isothermal exponential amplification coupled with hybridization chain reaction of DNAzyme nanowires. Biosens Bioelectron. 2015;64:566–571.
22. Linnes JC, Rodriguez NM, Liu L, et al. Polyethersulfone improves isothermal nucleic acid amplification compared to current paper-based diagnostics. Biomed Microdevices. 2016;18(2):30.
23. Poon LL, Leung CS, Chan KH, et al. Detection of human influenza A viruses by loop-mediated isothermal amplification. J Clin Microbiol. 2005;43(1):427–430.
24. Busson L, Mahadeb B, De Foor M, et al. Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza. Diagn Microbiol Infect Dis. 2017;87(3):238–242.
25. Trabattoni E, Le V, Pilmis B, et al. Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an emergency department. Am J Emerg Med. 2017. Epub ahead of print.
26. Bell JJ, Selvarangan R. Evaluation of the Alere I influenza A&B nucleic acid amplification test by use of respiratory specimens collected in viral transport medium. J Clin Microbiol. 2014;52(11):3992–3995.
27. Chapin KC, Flores-Cortez EJ. Performance of the molecular Alere i Influenza A&B test compared to that of the xpert flu A/B assay. J Clin Microbiol. 2015;53(2):706–709.
28. Nie S, Roth RB, Stiles J, et al. Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol. 2014;52(9):3339–3344.
29. Otto CC, Kaplan SE, Stiles J, et al. Rapid molecular detection and differentiation of influenza viruses A and B. J Vis Exp. 2017;(119).
30. Nolte FS, Gauld L, Barrett SB. Direct comparison of Alere i and cobas liat influenza A and B tests for rapid detection of influenza virus infection. J Clin Microbiol. 2016;54(11):2763–2766.
31. Hurtado JC, Mosquera MM, de Lazzari E, et al. Evaluation of a new, rapid, simple test for the detection of influenza virus. BMC Infect Dis. 2015;15:44.
32. Riazzo C, Perez-Ruiz M, Sanbonmatsu-Gamez S, et al. Analytical performance of the Alere i Influenza A&B assay for the rapid detection of influenza viruses. Enferm Infecc Microbiol Clin. 2017;35(7):438–440.
33. Berry GJ, Miller CR, Moreno Prats M, et al. Comparison of the Alere i and BD veritor in the detection of group A Streptococcus and the hypothetical impact of results on antibiotic utilization. J Clin Microbiol. 2018.
34. Chen JH, Lam HY, Yip CC, et al. Evaluation of the molecular xpert xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses. Diagn Microbiol Infect Dis. 2018;90(3):177-180.
35. Chiarella FC, Culebras E, Fuentes-Ferrer ME, et al. Evaluation of the Alere i Influenza A&B assay for rapid identification of influenza A and influenza B viruses. J Med Microbiol. 2016;65(6):456–461.
36. Hazelton B, Gray T, Ho J, et al. Detection of influenza A and B with the Alere i Influenza A & B: a novel isothermal nucleic acid amplification assay. Influenza Other Respir Viruses. 2015;9(3):151–154.
37. Jokela P, Vuorinen T, Waris M, et al. Performance of the Alere i influenza A&B assay and mariPOC test for the rapid detection of influenza A and B viruses. J Clin Virol. 2015;70:72–76.
38. Nguyen Van JC, Camelena F, Dahoun M, et al. Prospective evaluation of the Alere i Influenza A&B nucleic acid amplification versus Xpert Flu/RSV. Diagn Microbiol Infect Dis. 2016;85(1):19–22.
39. Young S, Illescas P, Nicasio J, et al. Diagnostic accuracy of the real-time PCR cobas((R)) Liat((R)) Influenza A/B assay and the Alere i Influenza A&B NEAR isothermal nucleic acid amplification assay for the detection of influenza using adult nasopharyngeal specimens. J Clin Virol. 2017;94:86–90.
40. Davis S, Allen AJ, O’Leary R, et al. Diagnostic accuracy and cost analysis of the Alere i Influenza A&B near-patient test using throat swabs. J Hosp Infect. 2017;97(3):301–309.
41. Yoon J, Yun SG, Nam J, et al. The use of saliva specimens for detection of influenza A and B viruses by rapid influenza diagnostic tests. J Virol Methods. 2017;243:15–19. Epub 2017 Jan 1019.
42. Ling L, Kaplan SE, Lopez JC, et al. Parallel validation of three molecular devices for simultaneous detection and identification of influenza A, B and respiratory syncytial viruses. J Clin Microbiol. 2017;56:e01691–17.
43. Popowitch EB, Miller MB. Performance Characteristics of Xpert Flu/RSV XC Assay. J Clin Microbiol. 2015;53(8):2720–2721.
44. Wahrenbrock MG, Matushek S, Boonlayangoor S, et al. Comparison of cepheid xpert Flu/RSV XC and biofire filmArray for detection of influenza A, influenza B, and respiratory syncytial virus. J Clin Microbiol. 2016;54(7):1902–1903.
45. Cohen DM, Kline J, May LS, et al. Accurate PCR detection of influenza A/B and RSV using the cepheid xpert Flu+RSV xpress assay in point-of-care settings: comparison to prodesse ProFlu. J Clin Microbiol. 2017;e01237–17.
46. Peters RM, Schnee SV, Tabatabai J, et al. Evaluation of Alere i RSV for rapid detection of respiratory syncytial virus in children hospitalized with acute respiratory tract infection. J Clin Microbiol. 2017;55(4):1032–1036.
47. Schnee SV, Pfeil J, Ihling CM, et al. Performance of the Alere i RSV assay for point-of-care detection of respiratory syncytial virus in children. BMC Infect Dis. 2017;17(1):767.